Lack of Hepatotoxicity with Naltrexone Treatment

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of clinical pharmacology

• Publication date

  1994-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/j.1552-4604.1994.tb04002.xPMID 7983232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Naltrexone: Lack of Effect on Hepatic Enzymes

  1988cited by this paper
• Use of narcotic antagonists to modify stereotypic self-licking, self-chewing, and scratching behavior in dogs.

  1988cited by this paper
• High-dose naloxone in tardive dyskinesia.

  1988cited by this paper
• Valproic acid hepatic fatalities

  1987cited by this paper
• Investigation into the use of narcotic antagonists in the treatment of a stereotypic behavior pattern (crib-biting) in the horse.

  1987cited by this paper
• Acute Hepatotoxicity After Excessively High Doses of Carbamazepine on Two Occasions

  1986cited by this paper
• Wirkungen der Neuroleptika auf die Leberfunktion, das blutbildende System,den Blutdruck und die Temperaturregulation

  1983cited by this paper
• Naloxone and self-mutilation.

  1983cited by this paper
• [Effects of neuroleptics on liver function, the hematopoietic system, blood pressure and temperature regulation. Comparison of clozapine, perazine and haloperidol by evaluating medical records].

  1983cited by this paper
• The effects of phenobarbital and diphenylhydantoin on liver function and morphology.

  1980cited by this paper
• Interim report on clinic intake and safety data collected from 17 NIDA-funded naltrexone studies.

  1976cited by this paper
• An analysis of naltrexone use--its efficacy, safety and potential.

  1976cited by this paper

• Safety and Effectiveness of Naltrexone in the Management of Alcohol Use Disorder in Patients With Alcohol-associated Cirrhosis: First Clinical Observation From Indian Cohort.

  2024cites this paper
• Medication treatment for alcohol use disorder in special populations.

  2023cites this paper
• High-Dose Naltrexone Treatment and Gender in Alcohol Dependence

  2016cites this paper
• Drugs of abuse and addiction: A slippery slope toward liver injury.

  2016cites this paper
• Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence

  2016cites this paper
• Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.

  2016cites this paper
• Pharmacological treatments for alcohol dependence 1 SAFETY AND TOLERABILITY OF PHARMACOLOGICAL TREATMENT OF ALCOHOL DEPENDENCE : COMPREHENSIVE REVIEW OF EVIDENCE

  2016cites this paper
• Potent Inhibition of Alcohol Self-Administration in Alcohol-Preferring Rats by a κ-Opioid Receptor Antagonist

  2014cites this paper
• An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone.

  2014cites this paper
• Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection.

  2012cites this paper
• Which psychotropic medications induce hepatotoxicity?

  2012cites this paper
• Safety, tolerability, and feasibility of high‐dose naltrexone in alcohol dependence: an open‐label study

  2011cites this paper
• The in vitro and in vivo formation and potency of 6β-naltrexol, the major human metabolite of naltrexone.

  2010cites this paper
• Effects of Naltrexone on Pain Sensitivity and Mood in Fibromyalgia: No Evidence for Endogenous Opioid Pathophysiology

  2009cites this paper
• Pharmacology of opioid agonists and antagonists

  2009cites this paper
• Naltrexone protects against lipopolysaccharide/D-galactosamine-induced hepatitis in mice.

  2008cites this paper
• Sustained-release naltrexone: novel treatment for opioid dependence

  2007cites this paper
• Adverse reactions to drugs used to treat alcoholism

  2007cites this paper
• Cholestasis and Endogenous Opioids

  2007cites this paper
• Safety of High-Dose Naltrexone Treatment: Hepatic Transaminase Profiles Among Outpatients

  2006cites this paper
• Study of hepatotoxicity of naltrexone in the treatment of alcoholism.

  2006cites this paper
• Endogenous opioids and liver disease

  2006cites this paper
• Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.

  2006cites this paper
• Effect of oral naltrexone on pruritus in cholestatic patients.

  2006cites this paper
• Pharmacotherapy Treatment in Substance-Dependent Correctional Populations: A Review

  2005cites this paper
• Bisphosphonates and osteonecrosis: analogy to phossy jaw

  2005cites this paper
• Achieving equal standards in medical student education: is a national exit examination the answer?

  2005cites this paper
• Riluzole: a glimmer of hope in the treatment of motor neurone disease

  2005cites this paper
• Allocation concealment and blinding: when ignorance is bliss

  2005cites this paper
• A case for altruistic surrogacy

  2005cites this paper
• Smoothing the transition to adult care

  2005cites this paper
• Allocation concealment and blinding: when ignorance is bliss

  2005cites this paper
• A case for altruistic surrogacy

  2005cites this paper
• Allocation concealment and blinding: when ignorance is bliss

  2005cites this paper
• Riluzole: a glimmer of hope in the treatment of motor neurone disease

  2005cites this paper
• Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature

  2004influential citation
• Implantes de naltrexona: un avance terapéutico, tanto comportamental como farmacológico Naltrexone implants: a real therapeutic avance both behavioural as well as pharmacological

  2003cites this paper
• Pathogenesis and management of alcoholic hepatitis

  2003cites this paper
• Naltrexone in the Prevention of Opioid Relapse

  2003cites this paper
• Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.

  2002cites this paper
• Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

  2002cites this paper
• Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation.

  2002cites this paper
• [Alcohol dependence treatment with naltrexone: safety assessment. Observation study group of alcoholic dependence].

  2000cites this paper
• The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group.

  1997cites this paper
• Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.

  1997cites this paper
• High-dose naltrexone and liver function safety.

  1997cites this paper
• Naltrexone in alcohol dependence.

  1997cites this paper
• [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].

  1996cites this paper
• Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.

  1996cites this paper
• Endogenous opiates: 1994.

  1995cites this paper
• Riluzole : a glimmer of hope in the treatment of motor neurone disease

  year unknowncites this paper